Inflazome, a biotech company developing new drugs to block harmful inflammation, has secured further investment of $63 million.
28 November 2018A new understanding of one of the body’s immune defence mechanisms could lead to the development of novel therapeutic targets for conditions such as cancer and autoimmune diseases, a University of Queensland study has revealed.
30 August 2018A discovery by Queensland scientists could be the key to stopping damage caused by uncontrolled inflammation in a range of common diseases including liver disease, Alzheimer’s and gout.
7 February 2018